| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373, 2017 | 831 | 2017 |
| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 513 | 2022 |
| Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021 | 131 | 2021 |
| Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ ACE project S Moreno‐Grau, I De Rojas, I Hernández, I Quintela, L Montrreal, ... Alzheimer's & Dementia 15 (10), 1333-1347, 2019 | 112 | 2019 |
| Follow-up of loci from the International Genomics of Alzheimer’s Disease Project identifies TRIP4 as a novel susceptibility gene A Ruiz, S Heilmann, T Becker, I Hernández, H Wagner, M Thelen, ... Translational psychiatry 4 (2), e358-e358, 2014 | 104 | 2014 |
| Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment A Lacour, A Espinosa, E Louwersheimer, S Heilmann, I Hernández, ... Molecular psychiatry 22 (1), 153-160, 2017 | 103 | 2017 |
| New insights on the genetic etiology of Alzheimer’s and related dementia C Bellenguez, F Küçükali, I Jansen, V Andrade, S Moreno-Grau, N Amin, ... MedRxiv, 2020.10. 01.20200659, 2020 | 66 | 2020 |
| Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer’s disease individuals: replication of diastolic blood pressure correlations and analysis of … A Ruiz, P Pesini, A Espinosa, V Pérez-Grijalba, S Valero, ... PLoS One 8 (11), e81334, 2013 | 45 | 2013 |
| Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study V Pérez-Grijalba, J Arbizu, J Romero, E Prieto, P Pesini, L Sarasa, ... Alzheimer's Research & Therapy 11, 1-9, 2019 | 44 | 2019 |
| Tissue radiation response with maximum Tsallis entropy O Sotolongo-Grau, D Rodriguez-Perez, JC Antoranz, O Sotolongo-Costa Physical review letters 105 (15), 158105, 2010 | 40 | 2010 |
| Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy … S Moreno–Grau, O Rodríguez‐Gómez, A Sanabria, A Pérez‐Cordón, ... Alzheimer's & Dementia 14 (5), 634-643, 2018 | 38* | 2018 |
| Assessment of cancer immunotherapy outcome in terms of the immune response time features D Rodriguez-Perez, O Sotolongo-Grau, RE Riquelme, O Sotolongo-Costa, ... Mathematical medicine and biology: a journal of the IMA 24 (3), 287-300, 2007 | 37 | 2007 |
| Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI) I de Rojas, J Romero, O Rodriguez-Gomez, P Pesini, A Sanabria, ... Alzheimer's research & therapy 10, 1-12, 2018 | 36 | 2018 |
| The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study P Bosco, A Redolfi, M Bocchetta, C Ferrari, A Mega, S Galluzzi, M Austin, ... Alzheimer's & Dementia 13 (9), 1013-1023, 2017 | 34 | 2017 |
| The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in subjective cognitive decline A Sanabria, M Alegret, O Rodriguez-Gomez, S Valero, O Sotolongo-Grau, ... Scientific Reports 8 (1), 3828, 2018 | 33 | 2018 |
| Impact of recruitment methods in subjective cognitive decline C Abdelnour, O Rodríguez-Gómez, M Alegret, S Valero, S Moreno-Grau, ... Journal of Alzheimer's Disease 57 (2), 625-632, 2017 | 30 | 2017 |
| FACEHBI: A prospective study of risk factors, biomarkers and cognition in a cohort of individuals with subjective cognitive decline. Study rationale and research protocols O Rodriguez-Gomez, A Sanabria, A Perez-Cordon, D Sanchez-Ruiz, ... J Prev Alzheimers Dis 4 (2), 100-108, 2017 | 28 | 2017 |
| Early detection of amyloid load using 18F-florbetaben PET S Bullich, N Roé-Vellvé, M Marquié, SM Landau, H Barthel, ... Alzheimer's research & therapy 13 (1), 1-15, 2021 | 25 | 2021 |
| Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative M Marquié, S Valero, M Castilla-Marti, J Martínez, O Rodríguez-Gómez, ... Alzheimer's research & therapy 12, 1-14, 2020 | 25 | 2020 |
| Common variants in Alzheimer’s disease: Novel association of six genetic variants with AD and risk stratification by polygenic risk scores I de Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, I Jansen, ... medRxiv, 19012021, 2019 | 23 | 2019 |
Mercè Boada, MD, PhDNeuróloga. MD, PhDEmail verificata su fundacioace.com
